Efficacy of antiretroviral therapy adherence interventions: A research synthesis of trials, 1996 to 2004

Journal of Acquired Immune Deficiency Syndromes

Volumn 41, Issue 3, 2006, Pages 285-297

  Amico, K Rivet ^a   Harman, Jennifer J ^a,b   Johnson, Blair T ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Adherence intervention; Antiretroviral therapy highly active antiretroviral therapy; HIV AIDS; Meta analysis; Research synthesis

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CALCULATION; CLINICAL PRACTICE; CLINICAL RESEARCH; DRUG EFFICACY; HEALTH CARE PERSONNEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE ADHERENCE; NONHUMAN; PRIORITY JOURNAL; PUBLICATION; REVIEW; TIME SERIES ANALYSIS; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANTI-HIV AGENTS; COUNSELING; HIV INFECTIONS; HUMANS; PATIENT COMPLIANCE; TREATMENT OUTCOME;

EID: 33645108959     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000197870.99196.ea     Document Type: Review

References (68)

1. Bartlett JA. Addressing the challenges of adherence. J Acquir Immune Defic Syndr. 2002;29(Suppl):S2-S10.
2. Pradier C, Carrieri P, Bentz L, et al. Impact of short-term adherence on virological and immunological success of HAART: a case study among French HIV-infected IDUs. Int J STD AIDS. 2001;12:324-328.
3. Demasi R, Toison J, Pham S, et al. Self-reported adherence to HAART and correlation with HIV RNA: initial results with the patient medication adherence questionnaire. Presented at: Sixth Conference on Retroviruses and Opportunistic Infections; 1999; Chicago.
4. Shor-Posner G, Lecusay R, Miguez-Burbano MJ, et al. Quality of life measures in the Miami HIV-1 infected drug abusers cohort: relationship to gender and disease status. J Subst Abuse. 2000;11:395-404.
5. Arnsten J, Demas P, Gourevitch M, et al. Adherence and viral load in HIV-infected drug users: comparison of self-report and medication event monitors (MEMS). Presented at: Seventh Conference on Retroviruses and Opportunistic Infections; 2000; San Francisco.
6. Bangsberg DR, Moss AR, Deeks SG. Paradoxes of adherence and drug resistance to HIV antiretroviral therapy. J Antimicrob Chemother. 2004;5:696-699.
7. Hogg RS, Yip B, Chan K, et al. Nonadherence to triple combination therapy is predictive of AIDS progression and death in HIV-positive men and women. Presented at: Seventh Conference on Retroviruses and Opportunistic Infections; 2000; San Francisco.
8. Manfredi R, Calza L, Chiodo F. Dual nucleoside analogue treatment in the era of highly active antiretroviral therapy HAART: a single-centre cross-sectional survey. J Antimicrob Chemother. 2001;48: 299-302.
9. Bangsberg DR, Hecht FM, Clague H, et al. Provider estimate and structured patient report of adherence compared with unannounced pill count. Presented at: Seventh Conference on Retroviruses and Opportunistic Infections; 2000; San Francisco.
10. Boden D, Hurley A, Zhang L, et al. HIV-1 drug resistance in newly infected individuals. JAMA. 1999;282:1135-1141.
11. Hecht FM, Colfax G, Swanson M, et al. Adherence and effectiveness of protease inhibitors in clinical practice. Presented at: Fifth Conference on Retroviruses and Opportunistic Infections; 1998; Chicago.
12. Harman JJ, Amico RA, Johnson BT. Standard of care: promoting antiretroviral adherence in clinical care. AIDS Care. 2005;2:237-251.
13. Fogarty L, Roter D, Larson S, et al. Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient Educ Couns. 2002;46:93-108.
14. Haddad M, Inch C, Glazier RH, et al. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. Cochrane Database Syst Rev. 2000;3:Cd001442.
15. Ickovics JR, Meade CS. Adherence to antiretroviral therapy among patients with HIV: a critical link between behavioral and biomedical sciences. J Acquir Immune Defic Syndr. 2002;31(Suppl):S98-S102.
16. Cote J, Godin G. Efficacy of interventions in improving adherence to antiretroviral therapy. Int J STD AIDS. 2005;16:335-343.
17. Simoni J, Frick P, Pantalone D, et al. Antiretroviral adherence interventions: a review of current literature and ongoing studies. Top HIV Med. 2003;11:185-198.
18. Hedges LV, Olkin I. Statistical Methods for Meta-Analysis. Orlando: Academic Press; 1985.
19. Johnson BT, Eagly AH. Quantitative synthesis of social psychological research. In: Reis HT, Judd CM eds. Handbook of Research Methods in Social and Personality Psychology. New York: Cambridge University Press; 2000:496-528.
20. Johnson BT. DSTAT 1.10: Software for the Meta-Analytic Review of Research Literatures. Hillsdale, NJ: Lawrence Erlbaum Associates; 1993.
21. Lipsey MW, Wilson DB. Practical Meta-Analysis. Thousand Oaks, CA: Sage Publications; 2001.
22. Chinn S. A simple method for converting an odds ratio to effect size for use in meta-analysis. Stat Med. 2000;19:3127-3131.
23. Erdfelder E, Faul F, Buchner A. GPOWER: a general power analysis program. Behav Res Methods Instrum Comput. 1996;28:1-11.
24. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
25. Lenth RV. Some practical guidelines for effective sample size determination. Am Stat. 2001;55:187-193.
26. Levine M, Ensom MH. Post hoc power analysis: an idea whose time has passed? Pharmacotherapy. 2001;21:405-409.
27. McPherson-Baker S, Malow RM, Penedo F, et al. Enhancing adherence to combination antiretroviral therapy in non-adherent HIV-positive men. AIDS Care. 2000;12:399-404.
28. Powell-Cope GM, White J, Henkelman EJ, et al. Qualitative and quantitative assessments of HAART adherence of substance-abusing women. AIDS Care. 2003;15:239-249.
29. Rigsby MO, Rosen MI, Beauvais JE, et al. Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention. J Gen Intern Med. 2000;15:841-847.
30. Margolin A, Avants SK, Warburton L, et al. A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection users. Health Psychol. 2003;22:223-228.
31. Tuldra A, Fumaz CR, Ferrer MJ, et al. Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2000;25:221-228.
32. Haubrich RH, Little SJ, Currier JS, et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS. 1999;13:1099-1107.
33. Kirkland LR, Fischl MA, Tashima KT, et al. Response to lamivudine-zidovudine plus abacavir twice daily in antiretroviral-naïve, incarcerated patients with HIV infection taking directly observed treatment. Clin Infect Dis. 2002;34:511-518.
34. Avants SK, Margolin A, Warburton LA, et al. Predictors of non-adherence to HIV-related medication regimens during methadone stabilization. Am J Addict. 2001;10:69-78.
35. Catz SL, Kelley JA, Bogart LM, et al. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000;19:124-133.
36. Mihalko SL, Brenes GA, Farmer DF, et al. Challenges and innovations in enhancing adherence. Control Clin Trials. 2004;25:447-457.
37. Arnsten JH, Demas PA, Farsadegan H, et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis. 2001;33: 1417-1423.
38. Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological outcome. AIDS. 2002;16:269-277.
39. Kleeberger CA, Phair JP, Strathdee SA, et al. Effect of computer-assisted self-interviews on reporting of sexual HIV risk behaviours in a general populations sample: a methodological experiment. J Acquir Immune Defic Syndr. 2001;26:82-92.
40. Knobel H, Alonso J, Casado JL, et al. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study. AIDS. 2002;16:605-613.
41. Moatti JP, Spire B. Living with HIV/AIDS and adherence to antiretroviral treatments. In: Moatti J-P, Souteyrand Y, Prieur A, et al eds. AIDS in Europe: New Challenges for the Social Sciences. New York: Routledge; 2000:57-73.
42. Murri R, Ammassari A, Gallicano K, et al. Patient-reported non-adherence to HAART is related to protease inhibitor levels. J Acquir Immune Defic Syndr. 2000;24:123-128.
43. Nieuwkerk PT, Sprangers MA, Burger DM, et al. Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study. Arch Intern Med. 2001;161:1962-1968.
44. Samet JH, Sullivan LM, Traphagen ET, et al. Measuring adherence among HIV-infected persons: is MEMS consummate technology? AIDS Behav. 2001;5:21-30.
45. Altice FL, Mostashari F, Friedland GH. Trust and the acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;28:47-58.
46. Holzemer WL, Corless IB, Nokes KM, et al. Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care STDS. 1999;13:185-197.
47. Horne R. Patients' beliefs about treatment: the hidden determinant of treatment outcome? J Psychosom Res. 1999;47:491-495.
48. Gao X, Nau DP, Rosenbluth SA, et al. The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care. 2000;12:387-398.
49. Singh N, Berman SM, Swindells S, et al. Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clin Infect Dis. 1999;29:824-830.
50. Bellg AJ. Maintenance of health behaviour change in preventive cardiology: internalization and self-regulation of new behaviours. Behav Modif. 2003;27:103-131.
51. Anonymous. Program increases HAART adherence in HIV patients. AIDS Alert. 1999;1:31-32.
52. DiIorio C, Resnicow K, McDonnell M, et al. Using motivational interviewing to promote adherence to antiretroviral medications: a pilot study. J Assoc Nurses AIDS Care. 2003;14:52-62.
53. Fairley CK, Levy R, Rayner CR, et al. Randomized trial of an adherence programme for clients with HIV. Int J STD AIDS. 2003;14:805-809.
54. Goujard C, Bernard N, Sohier N, et al. Impact of a patient education program on adherence to HIV medication. J Acquir Immune Defic Syndr. 2003;34:191-194.
55. Holzemer WL, Henry SB, Portillo CJ, et al. The client adherence profiling-intervention tailoring (CAP-IT) intervention for enhancing adherence to HIV/AIDS medications: a pilot study. J Assoc Nurses AIDS Care. 2000;11:36-44.
56. Lyon ME, Trexler C, Akpan-Townsend C, et al. A family group approach to increasing adherence to therapy in HIV-infected youths: results of a pilot project. AIDS Patient Care STDS. 2003;17:299-308.
57. Malow RM, McPherson S, Klimas N, et al. Alcohol and drug abuse: adherence to complex combination antiretroviral therapies by HIV-positive drug abusers. Psychiatr Serv. 1998;49:1021-1024.
58. Mann T. Effects of future writing and optimism on health behaviors in HIV-infected women. Ann Behav Med. 2001;23:26-33.
59. Molassiotis A, Lopez NV, Chung WY, et al. A pilot study of the effects of a behavioural intervention on treatment adherence in HIV-infected patients. AIDS Care. 2003;15:125-135.
60. Murphy DA, Lu MC, Martin D, et al. Results of a pilot intervention trial to improve antiretroviral adherence among HIV-positive patients. J Assoc Nurses AIDS Care. 2002;13:57-69.
61. Pradier C, Bentz L, Spire B, et al. Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study. HIV Clin Trials. 2003;4:121-131.
62. Rawlings MK, Thompson MA, Farthing CF, et al. Impact of an educational program on efficacy and adherence with a twice-daily lamivudine/zidovudine/ abacavir regimen in underrepresented HIV-infected patients. J Acquir Immune Defic Syndr. 2003;34:174-183.
63. Safren SA, Otto MW, Worth JL, et al. Two strategies to increase adherence to HIV antiretroviral medication: Life-steps and medication monitoring. Behav Res Ther. 2001;39:1151-1162.
64. Safren SA, Hendriksen ES, DeSousa N, et al. Use of an on-line pager system to increase adherence to antiretroviral medications. AIDS Care. 2003;15:787-793.
65. Smith SR, Rublein JC, Marcus C, et al. A medication self-management program to improve adherence to HIV therapy regimens. Patient Educ Couns. 2003;50:187-199.
66. Stenzel MS, McKenzie M, Mitty JA, et al. Enhancing adherence to HAART: a pilot program of modified directly observed therapy. AIDS Reader. 2001;11:317-328.
67. Tesoriero J, French T, Weiss L, et al. Stability of adherence to highly active antiretroviral therapy over time among clients enrolled in the treatment adherence demonstration project. J Acquir Immune Defic Syndr. 2003;33:484-493.
68. Mitty JA, McKenzie M, Stenzel M, et al. Modified directly observed therapy for treatment of human immunodeficiency virus [research letter]. JAMA. 1999;282:1334.